Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-01-20

AUTHORS

Tsutomu Murakami, Norihito Nakamura, Makoto Natsumeda, Shingo Matsumoto, Katsuaki Sakai, Yohei Ohno, Gaku Nakazawa, Norihiko Shinozaki, Yuji Ikari

ABSTRACT

Managing right-sided chronic heart failure (CHF) due to tricuspid regurgitation (TR) remains a clinical challenge. Tolvaptan (TLV), a vasopressin V2 receptor inhibitor, is effective in controlling decompensated HF. However, its effects on right-sided CHF caused by TR are unclear. We sought to clarify the effects of TLV in CHF patients complicated with TR. The cohort consisted of 33 CHF patients with moderate or severe TR and permanent atrial fibrillation, who required hospitalization for HF. We observed 19 patients treated with TLV plus conventional therapies (TLV group) and 14 patients with conventional therapies alone (conventional group). Clinical characteristics, echocardiographic parameters, and laboratory data were investigated. Baseline characteristics were similar between groups. In the TLV group, the severity of TR at admission was 73.7% moderate and 26.3% severe. In the conventional group, these percentages were 85.7% and 14.3%, respectively. During the follow-up, the severity of TR improved in the TLV group (trivial–mild: 52.6%; moderate: 36.8%; severe: 10.5%) (p < 0.01). However, it did not improve in the conventional group (trivial–mild: 21.4%; moderate: 50.0%; severe: 28.6%) (p = 0.08). The diameter of the tricuspid annulus (p < 0.01), basal (p = 0.02), and mid right ventricle (p = 0.04) was reduced at follow-up in the TLV group. Nevertheless, these parameters did not change in the conventional group. Serum creatinine levels were maintained (p = 0.74) in the TLV group, but deteriorated in the conventional group (p = 0.03). TLV reduced right ventricular dimensions and improved TR without deterioration of renal function. Thus, TLV may be a new drug for the treatment of CHF patients with TR. More... »

PAGES

1153-1161

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-021-02014-7

DOI

http://dx.doi.org/10.1007/s00380-021-02014-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1144819383

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35050407


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Echocardiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Ventricles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tolvaptan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tricuspid Valve Insufficiency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murakami", 
        "givenName": "Tsutomu", 
        "id": "sg:person.01355754116.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355754116.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "Norihito", 
        "id": "sg:person.013211020232.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013211020232.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Natsumeda", 
        "givenName": "Makoto", 
        "id": "sg:person.01260160576.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260160576.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsumoto", 
        "givenName": "Shingo", 
        "id": "sg:person.01042140343.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042140343.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakai", 
        "givenName": "Katsuaki", 
        "id": "sg:person.01134671347.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134671347.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohno", 
        "givenName": "Yohei", 
        "id": "sg:person.01042040454.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042040454.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kindai University Faculty of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258622.9", 
          "name": [
            "Department of Cardiology, Kindai University Faculty of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakazawa", 
        "givenName": "Gaku", 
        "id": "sg:person.01050275451.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050275451.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shinozaki", 
        "givenName": "Norihiko", 
        "id": "sg:person.01224276440.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224276440.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ikari", 
        "givenName": "Yuji", 
        "id": "sg:person.01230000060.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230000060.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11748-016-0678-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050926959", 
          "https://doi.org/10.1007/s11748-016-0678-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-014-0194-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003890559", 
          "https://doi.org/10.1007/s40262-014-0194-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40256-018-0304-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107227809", 
          "https://doi.org/10.1007/s40256-018-0304-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-01-20", 
    "datePublishedReg": "2022-01-20", 
    "description": "Managing right-sided chronic heart failure (CHF) due to tricuspid regurgitation (TR) remains a clinical challenge. Tolvaptan (TLV), a vasopressin V2 receptor inhibitor, is effective in controlling decompensated HF. However, its effects on right-sided CHF caused by TR are unclear. We sought to clarify the effects of TLV in CHF patients complicated with TR. The cohort consisted of 33 CHF patients with moderate or severe TR and permanent atrial fibrillation, who required hospitalization for HF. We observed 19 patients treated with TLV plus conventional therapies (TLV group) and 14 patients with conventional therapies alone (conventional group). Clinical characteristics, echocardiographic parameters, and laboratory data were investigated. Baseline characteristics were similar between groups. In the TLV group, the severity of TR at admission was 73.7% moderate and 26.3% severe. In the conventional group, these percentages were 85.7% and 14.3%, respectively. During the follow-up, the severity of TR improved in the TLV group (trivial\u2013mild: 52.6%; moderate: 36.8%; severe: 10.5%) (p\u2009<\u20090.01). However, it did not improve in the conventional group (trivial\u2013mild: 21.4%; moderate: 50.0%; severe: 28.6%) (p\u2009=\u20090.08). The diameter of the tricuspid annulus (p\u2009<\u20090.01), basal (p\u2009=\u20090.02), and mid right ventricle (p\u2009=\u20090.04) was reduced at follow-up in the TLV group. Nevertheless, these parameters did not change in the conventional group. Serum creatinine levels were maintained (p\u2009=\u20090.74) in the TLV group, but deteriorated in the conventional group (p\u2009=\u20090.03). TLV reduced right ventricular dimensions and improved TR without deterioration of renal function. Thus, TLV may be a new drug for the treatment of CHF patients with TR.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00380-021-02014-7", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "chronic heart failure", 
      "severity of TR", 
      "tricuspid regurgitation", 
      "right ventricular dimensions", 
      "TLV group", 
      "CHF patients", 
      "conventional group", 
      "heart failure", 
      "ventricular dimensions", 
      "conventional therapy", 
      "right-sided heart failure", 
      "effects of tolvaptan", 
      "impact of tolvaptan", 
      "permanent atrial fibrillation", 
      "serum creatinine levels", 
      "severe tricuspid regurgitation", 
      "echocardiographic parameters", 
      "clinical characteristics", 
      "baseline characteristics", 
      "creatinine levels", 
      "renal function", 
      "atrial fibrillation", 
      "tricuspid annulus", 
      "right ventricle", 
      "receptor inhibitors", 
      "clinical challenge", 
      "tolvaptan", 
      "patients", 
      "new drugs", 
      "laboratory data", 
      "regurgitation", 
      "therapy", 
      "severity", 
      "group", 
      "hospitalization", 
      "failure", 
      "admission", 
      "fibrillation", 
      "cohort", 
      "ventricle", 
      "drugs", 
      "basal", 
      "treatment", 
      "inhibitors", 
      "effect", 
      "percentage", 
      "deterioration", 
      "levels", 
      "improvement", 
      "annulus", 
      "characteristics", 
      "HF", 
      "function", 
      "data", 
      "impact", 
      "diameter", 
      "challenges", 
      "parameters", 
      "dimensions"
    ], 
    "name": "Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure", 
    "pagination": "1153-1161", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1144819383"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-021-02014-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35050407"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-021-02014-7", 
      "https://app.dimensions.ai/details/publication/pub.1144819383"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_941.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00380-021-02014-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-02014-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-02014-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-02014-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-02014-7'


 

This table displays all metadata directly associated to this object as RDF triples.

215 TRIPLES      21 PREDICATES      93 URIs      82 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-021-02014-7 schema:about N411c64fd62514462a1d9e5165cc6a2d1
2 N6565b0554f794817abe97127423ba292
3 N929f7b421c2b4267ab682d21509bbff7
4 Nae1e72a67df4418194499f73db8d4ebf
5 Nb10df33fc0e344269731caab05ba0c1f
6 Ne8eb722399b245b6a3d07dae5c1ca39c
7 anzsrc-for:11
8 anzsrc-for:1102
9 schema:author Nec5cda7e132f4b06979948efd50f4812
10 schema:citation sg:pub.10.1007/s11748-016-0678-4
11 sg:pub.10.1007/s40256-018-0304-1
12 sg:pub.10.1007/s40262-014-0194-6
13 schema:datePublished 2022-01-20
14 schema:datePublishedReg 2022-01-20
15 schema:description Managing right-sided chronic heart failure (CHF) due to tricuspid regurgitation (TR) remains a clinical challenge. Tolvaptan (TLV), a vasopressin V2 receptor inhibitor, is effective in controlling decompensated HF. However, its effects on right-sided CHF caused by TR are unclear. We sought to clarify the effects of TLV in CHF patients complicated with TR. The cohort consisted of 33 CHF patients with moderate or severe TR and permanent atrial fibrillation, who required hospitalization for HF. We observed 19 patients treated with TLV plus conventional therapies (TLV group) and 14 patients with conventional therapies alone (conventional group). Clinical characteristics, echocardiographic parameters, and laboratory data were investigated. Baseline characteristics were similar between groups. In the TLV group, the severity of TR at admission was 73.7% moderate and 26.3% severe. In the conventional group, these percentages were 85.7% and 14.3%, respectively. During the follow-up, the severity of TR improved in the TLV group (trivial–mild: 52.6%; moderate: 36.8%; severe: 10.5%) (p < 0.01). However, it did not improve in the conventional group (trivial–mild: 21.4%; moderate: 50.0%; severe: 28.6%) (p = 0.08). The diameter of the tricuspid annulus (p < 0.01), basal (p = 0.02), and mid right ventricle (p = 0.04) was reduced at follow-up in the TLV group. Nevertheless, these parameters did not change in the conventional group. Serum creatinine levels were maintained (p = 0.74) in the TLV group, but deteriorated in the conventional group (p = 0.03). TLV reduced right ventricular dimensions and improved TR without deterioration of renal function. Thus, TLV may be a new drug for the treatment of CHF patients with TR.
16 schema:genre article
17 schema:isAccessibleForFree false
18 schema:isPartOf N5c44857a8c0449e8b4d0b1f96f6349cc
19 N6b73e95ce0bf46bc9c5ff69e5d777204
20 sg:journal.1095887
21 schema:keywords CHF patients
22 HF
23 TLV group
24 admission
25 annulus
26 atrial fibrillation
27 basal
28 baseline characteristics
29 challenges
30 characteristics
31 chronic heart failure
32 clinical challenge
33 clinical characteristics
34 cohort
35 conventional group
36 conventional therapy
37 creatinine levels
38 data
39 deterioration
40 diameter
41 dimensions
42 drugs
43 echocardiographic parameters
44 effect
45 effects of tolvaptan
46 failure
47 fibrillation
48 function
49 group
50 heart failure
51 hospitalization
52 impact
53 impact of tolvaptan
54 improvement
55 inhibitors
56 laboratory data
57 levels
58 new drugs
59 parameters
60 patients
61 percentage
62 permanent atrial fibrillation
63 receptor inhibitors
64 regurgitation
65 renal function
66 right ventricle
67 right ventricular dimensions
68 right-sided heart failure
69 serum creatinine levels
70 severe tricuspid regurgitation
71 severity
72 severity of TR
73 therapy
74 tolvaptan
75 treatment
76 tricuspid annulus
77 tricuspid regurgitation
78 ventricle
79 ventricular dimensions
80 schema:name Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure
81 schema:pagination 1153-1161
82 schema:productId N18ba88d21b524e7a9ef192cd1e56b0af
83 N6829995cd8fa41798f3808f8bd40a25c
84 Nc1f197c7066f4eeabf8ff98b8e55c069
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1144819383
86 https://doi.org/10.1007/s00380-021-02014-7
87 schema:sdDatePublished 2022-09-02T16:07
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher N430b740904774a1ca728e55ec2b288a2
90 schema:url https://doi.org/10.1007/s00380-021-02014-7
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N18ba88d21b524e7a9ef192cd1e56b0af schema:name doi
95 schema:value 10.1007/s00380-021-02014-7
96 rdf:type schema:PropertyValue
97 N2ff9cbbbbf024d87b29b8d8cb7fa0828 rdf:first sg:person.013211020232.74
98 rdf:rest N4be06e1ee66e49858d3d63e9698e7277
99 N411c64fd62514462a1d9e5165cc6a2d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Heart Failure
101 rdf:type schema:DefinedTerm
102 N430b740904774a1ca728e55ec2b288a2 schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 N4be06e1ee66e49858d3d63e9698e7277 rdf:first sg:person.01260160576.70
105 rdf:rest N996796fc7ec14b54aeb150d060a53781
106 N5c44857a8c0449e8b4d0b1f96f6349cc schema:volumeNumber 37
107 rdf:type schema:PublicationVolume
108 N6565b0554f794817abe97127423ba292 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Tricuspid Valve Insufficiency
110 rdf:type schema:DefinedTerm
111 N6829995cd8fa41798f3808f8bd40a25c schema:name dimensions_id
112 schema:value pub.1144819383
113 rdf:type schema:PropertyValue
114 N6b73e95ce0bf46bc9c5ff69e5d777204 schema:issueNumber 7
115 rdf:type schema:PublicationIssue
116 N929f7b421c2b4267ab682d21509bbff7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Echocardiography
118 rdf:type schema:DefinedTerm
119 N996796fc7ec14b54aeb150d060a53781 rdf:first sg:person.01042140343.48
120 rdf:rest Nabf45a28c5ea42d88cd658eb57419deb
121 Nabf45a28c5ea42d88cd658eb57419deb rdf:first sg:person.01134671347.38
122 rdf:rest Neba630dedddf48559025423da40742e5
123 Nae1e72a67df4418194499f73db8d4ebf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Heart Ventricles
125 rdf:type schema:DefinedTerm
126 Nb10df33fc0e344269731caab05ba0c1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Humans
128 rdf:type schema:DefinedTerm
129 Nbf228070b5a04074b11fa6f044a0200e rdf:first sg:person.01224276440.03
130 rdf:rest Nd12e75a394494d148dc60b7dc6b1c193
131 Nc1f197c7066f4eeabf8ff98b8e55c069 schema:name pubmed_id
132 schema:value 35050407
133 rdf:type schema:PropertyValue
134 Nd12e75a394494d148dc60b7dc6b1c193 rdf:first sg:person.01230000060.40
135 rdf:rest rdf:nil
136 Ne8eb722399b245b6a3d07dae5c1ca39c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Tolvaptan
138 rdf:type schema:DefinedTerm
139 Nea3627ea221c4dfb8dea034e7aa67bf0 rdf:first sg:person.01050275451.86
140 rdf:rest Nbf228070b5a04074b11fa6f044a0200e
141 Neba630dedddf48559025423da40742e5 rdf:first sg:person.01042040454.15
142 rdf:rest Nea3627ea221c4dfb8dea034e7aa67bf0
143 Nec5cda7e132f4b06979948efd50f4812 rdf:first sg:person.01355754116.43
144 rdf:rest N2ff9cbbbbf024d87b29b8d8cb7fa0828
145 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
146 schema:name Medical and Health Sciences
147 rdf:type schema:DefinedTerm
148 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
149 schema:name Cardiorespiratory Medicine and Haematology
150 rdf:type schema:DefinedTerm
151 sg:journal.1095887 schema:issn 0910-8327
152 1615-2573
153 schema:name Heart and Vessels
154 schema:publisher Springer Nature
155 rdf:type schema:Periodical
156 sg:person.01042040454.15 schema:affiliation grid-institutes:grid.265061.6
157 schema:familyName Ohno
158 schema:givenName Yohei
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042040454.15
160 rdf:type schema:Person
161 sg:person.01042140343.48 schema:affiliation grid-institutes:grid.265061.6
162 schema:familyName Matsumoto
163 schema:givenName Shingo
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042140343.48
165 rdf:type schema:Person
166 sg:person.01050275451.86 schema:affiliation grid-institutes:grid.258622.9
167 schema:familyName Nakazawa
168 schema:givenName Gaku
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050275451.86
170 rdf:type schema:Person
171 sg:person.01134671347.38 schema:affiliation grid-institutes:grid.265061.6
172 schema:familyName Sakai
173 schema:givenName Katsuaki
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134671347.38
175 rdf:type schema:Person
176 sg:person.01224276440.03 schema:affiliation grid-institutes:grid.265061.6
177 schema:familyName Shinozaki
178 schema:givenName Norihiko
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224276440.03
180 rdf:type schema:Person
181 sg:person.01230000060.40 schema:affiliation grid-institutes:grid.265061.6
182 schema:familyName Ikari
183 schema:givenName Yuji
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230000060.40
185 rdf:type schema:Person
186 sg:person.01260160576.70 schema:affiliation grid-institutes:grid.265061.6
187 schema:familyName Natsumeda
188 schema:givenName Makoto
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260160576.70
190 rdf:type schema:Person
191 sg:person.013211020232.74 schema:affiliation grid-institutes:grid.265061.6
192 schema:familyName Nakamura
193 schema:givenName Norihito
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013211020232.74
195 rdf:type schema:Person
196 sg:person.01355754116.43 schema:affiliation grid-institutes:grid.265061.6
197 schema:familyName Murakami
198 schema:givenName Tsutomu
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355754116.43
200 rdf:type schema:Person
201 sg:pub.10.1007/s11748-016-0678-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050926959
202 https://doi.org/10.1007/s11748-016-0678-4
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/s40256-018-0304-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107227809
205 https://doi.org/10.1007/s40256-018-0304-1
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/s40262-014-0194-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003890559
208 https://doi.org/10.1007/s40262-014-0194-6
209 rdf:type schema:CreativeWork
210 grid-institutes:grid.258622.9 schema:alternateName Department of Cardiology, Kindai University Faculty of Medicine, Osaka, Japan
211 schema:name Department of Cardiology, Kindai University Faculty of Medicine, Osaka, Japan
212 rdf:type schema:Organization
213 grid-institutes:grid.265061.6 schema:alternateName Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan
214 schema:name Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, 259-1193, Isehara, Kanagawa, Japan
215 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...